10:50:00 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-10-23 Kvartalsrapport 2024-Q3
2024-07-15 Kvartalsrapport 2024-Q2
2024-05-10 Ordinarie utdelning ALIF B 0.50 SEK
2024-05-08 Årsstämma 2024
2024-04-24 Kvartalsrapport 2024-Q1
2024-02-02 Bokslutskommuniké 2023
2023-10-26 Kvartalsrapport 2023-Q3
2023-07-14 Kvartalsrapport 2023-Q2
2023-05-05 Ordinarie utdelning ALIF B 1.20 SEK
2023-05-04 Årsstämma 2023
2023-04-26 Kvartalsrapport 2023-Q1
2023-02-02 Bokslutskommuniké 2022
2022-10-27 Kvartalsrapport 2022-Q3
2022-07-15 Kvartalsrapport 2022-Q2
2022-05-06 Ordinarie utdelning ALIF B 2.00 SEK
2022-05-05 Årsstämma 2022
2022-04-28 Kvartalsrapport 2022-Q1
2022-02-04 Bokslutskommuniké 2021
2021-10-22 Kvartalsrapport 2021-Q3
2021-07-15 Kvartalsrapport 2021-Q2
2021-05-06 Ordinarie utdelning ALIF B 1.50 SEK
2021-05-05 Årsstämma 2021
2021-04-28 Kvartalsrapport 2021-Q1
2021-02-03 Bokslutskommuniké 2020
2020-11-20 Bonusutdelning ALIF B 0.5
2020-11-19 Extra Bolagsstämma 2020
2020-10-22 Kvartalsrapport 2020-Q3
2020-07-17 Kvartalsrapport 2020-Q2
2020-05-27 Split ALIF B 1:4
2020-05-08 Ordinarie utdelning ALIF B 0.00 SEK
2020-05-07 Årsstämma 2020
2020-04-28 Kvartalsrapport 2020-Q1
2020-02-06 Bokslutskommuniké 2019
2019-11-07 Kvartalsrapport 2019-Q3
2019-07-12 Kvartalsrapport 2019-Q2
2019-05-10 Ordinarie utdelning ALIF B 2.20 SEK
2019-05-09 Kvartalsrapport 2019-Q1
2019-05-09 Årsstämma 2019
2019-02-12 Bokslutskommuniké 2018
2018-12-20 Extra Bolagsstämma 2018
2018-11-07 Kvartalsrapport 2018-Q3
2018-07-13 Kvartalsrapport 2018-Q2
2018-06-01 Ordinarie utdelning ALIF B 2.20 SEK
2018-05-31 Årsstämma 2018
2018-04-27 Kvartalsrapport 2018-Q1
2018-02-13 Bokslutskommuniké 2017
2017-10-26 Kvartalsrapport 2017-Q3
2017-07-17 Kvartalsrapport 2017-Q2
2017-05-30 Ordinarie utdelning ALIF B 1.50 SEK
2017-05-29 Årsstämma 2017
2017-04-28 Kvartalsrapport 2017-Q1
2017-02-16 Bokslutskommuniké 2016
2016-10-27 Kvartalsrapport 2016-Q3
2016-09-02 Ordinarie utdelning ALIF B 0.00 SEK
2016-09-01 Årsstämma 2016
2016-07-15 Kvartalsrapport 2016-Q2

Beskrivning

LandSverige
ListaLarge Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
AddLife är en koncern med verksamhet inom life-science sektorn. Inom koncernen återfinns specialisering främst mot diagnostik, medicinteknik och biomedicinsk forskning. Verksamhet innehas främst i Norden och Baltikum med kunder inom vård och omsorg, samt forskningsinstitut. Addlife bildades under 2015 vid en avknoppning ur Addtech koncernen. Bolaget har sitt huvudkontor i Stockholm.
2019-08-13 15:30:00

Today AddLife signed an agreement for the acquisition of all shares in the Danish companies Lab-Vent Controls A/S and Koldt & Ryø El A/S. The companies are leaders on the Danish market in ventilation solutions for laboratories and cleanrooms. The acquisitions are complement to AddLife's operations in the Danish market within the Labtech business area.

The companies have successfully established themselves as leading providers in the Danish market in specialised ventilation solutions for laboratories and cleanrooms where high demands are placed on air flow control and monitoring. The companies provide solutions based on innovative proprietary products and technical know-how and service. The companies are complement to AddLife's operations in the company Holm & Halby, currently a leading laboratory equipment provider specialist in cleanrooms on the Danish market.

The companies typical end customers include the pharmaceutical industry and academic research institutions.
- The acquisitions means that we more clearly establish AddLife as a complete supplier of advanced solutions in cleanroom technology in the Danish market, says Peter Simonsbacka, Business Area Manager Labtech, AddLife AB

The company currently has 20 employees and sales of DKK 36 million, on the Danish market.
The deal will close on 15 August 2019. The acquisitions are expected to have a marginally favourable impact on AddLife's earnings per share during the current financial year.
Stockholm 13 August 2019
AddLife AB (publ.)

For further information, please contact
Kristina Willgård, CEO, AddLife AB, +46 705 10 12 23
Peter Simonsbacka, Business Area Manager, Labtech, AddLife AB, +46 702 87 00 87

AddLife is an independent player in Life Science that offers high-quality products, services and advice to both the private and public sector, mainly in the Nordic region and the rest of Europe.  AddLife has approximately 900 employees in about 40 operating subsidiaries that operate under their own brands. The Group has net sales of around SEK 3.0 billion. AddLife shares are listed on NASDAQ Stockholm.
This information was issued for publication on 13 August 2019 at 15:30 (CET).